The Confusing Terminology of "Medical Cannabis" and Cannabinoid Products
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Confusion surrounds medical cannabis terminology due to market expansion. This commentary clarifies cannabinoid definitions and discusses how vague terms may misrepresent evidence-based medical uses for cannabis.
Area Of Science
- Pharmacology
- Medical Therapeutics
- Cannabinoid Science
Background
- The expanding market for medical cannabis and medical marijuana has created significant confusion regarding cannabinoid terminology.
- Public understanding of cannabis-based medications is often unclear, impacting perceptions of their medical utility.
Purpose Of The Study
- To provide clear definitions for cannabinoid terminology.
- To examine Food and Drug Administration (FDA)-approved and non-FDA-approved cannabinoid medications.
- To discuss how imprecise language contributes to public misperceptions about evidence-based medical indications for cannabis.
Main Methods
- Literature review and analysis of current cannabinoid terminology.
- Examination of FDA-approved and non-FDA-approved cannabinoid products.
- Discussion of the impact of terminology on public perception.
Main Results
- Cannabinoid terminology is often used vaguely, leading to confusion.
- A distinction exists between FDA-approved cannabinoid medications and non-approved products.
- Vague terminology can foster a misperception that cannabis lacks evidence-based medical applications.
Conclusions
- Clear and precise cannabinoid terminology is essential for accurate public understanding.
- Differentiating between approved and non-approved cannabinoid products is crucial.
- Addressing terminological ambiguity can help correct misperceptions regarding the medical indications for cannabis.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...